دورية أكاديمية

Renal Function and Outcome After Continuous Flow Left Ventricular Assist Device Implantation.

التفاصيل البيبلوغرافية
العنوان: Renal Function and Outcome After Continuous Flow Left Ventricular Assist Device Implantation.
المؤلفون: Sandner, Sigrid E., Zimpfer, Daniel, Zrunek, Philipp, Rajek, Angela, Schima, Heinrich, Dunkler, Daniela, Grimm, Michael, Wolner, Ernst, Wieselthaler, Georg M.
المصدر: Annals of Thoracic Surgery; Apr2009, Vol. 87 Issue 4, p1072-1078, 7p
مصطلحات موضوعية: HEART transplant recipients, LEFT heart ventricle surgery, KIDNEY diseases, IMPLANTED cardiovascular instruments, HEALTH outcome assessment, HEART failure, RETROSPECTIVE studies, GLOMERULAR filtration rate
مستخلص: Background: Renal dysfunction as a risk factor with the use of left ventricular assist devices (LVAD) is controversial. We determined the effect of renal function on outcomes after continuous flow LVAD implantation. Methods: Eighty-six patients with advanced heart failure undergoing continuous flow LVAD implantation as bridge to transplantation from November 1998 to July 2007 were retrospectively analyzed. Renal function was assessed using the Modification of Diet in Renal Disease study–derived glomerular filtration rates (GFR [mL · min−1 · 1.73 m−2]). Patients were categorized into two groups based on pre-LVAD GFR: those with normal renal function (GFR > 60, n = 46), and those with renal dysfunction (GFR < 60, n = 40). Results: Post-LVAD survival at 1, 3, and 6 months for GFR greater than 60 was 91.3%, 79.9%, 72.6%, respectively, and for GFR less than 60, it was 92.5%, 66.5%, 47.9%, respectively (p = 0.038). Bridge-to-transplant rate was lower for GFR less than 60 than for GFR greater than 60 (40.0% versus 63.0%, p = 0.033). For GFR less than 60, GFR improved on LVAD support: implant to month 6, 41.7 ± 11.5 to 62.7 ± 25.0 (p = 0.021). Post-LVAD survival was improved in GFR less than 60 patients who after LVAD implantation recovered renal function to GFR greater than 60 (p < 0.001). Patients with post-LVAD renal failure had significantly lower post-LVAD survival regardless of pre-LVAD renal function (p < 0.001). Conclusions: Patients with renal dysfunction have poorer outcomes after continuous flow LVAD implantation. However, renal function improves after LVAD implantation and is associated with improved survival. Our data underscore the importance of end-organ function in patient selection for LVAD therapy. [Copyright &y& Elsevier]
Copyright of Annals of Thoracic Surgery is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Supplemental Index
الوصف
تدمد:00034975
DOI:10.1016/j.athoracsur.2009.01.022